Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Brexit

Refrigeration storage for no-deal Brexit medicines stockpiles to cost £1m

The cold-chain storage warehouses required should the UK leave the EU without a deal in place are expected to cost the UK £1m.

Cold chain warehouse

Source: Shutterstock.com

Stephen Hammond, the minister of state for health and social care, has said that refrigerated storage for medicines that the UK would require if it left the EU without a withdrawal agreement in place would cost £1m

The government is expecting to spend around £1m on refrigerated storage for medicine stockpiles in the event of a no-deal Brexit.

In answer to a parliamentary question on cold drug storage, Stephen Hammond, minister of state for health and social care, said contract agreements for storage facilities for stockpiled medicines “have recently been signed or will be signed imminently”.

The contract, which was put out to tender in October 2018, will provide capacity for “53,000 pallets of ambient storage, 5,000 pallets of refrigerated storage and 850 pallets of controlled-drug storage” from the beginning of February 2019 for 12–18 months, he said.

Hammond added: “This is expected to cost the government in the low tens of millions of pounds with the refrigerated storage expected to cost circa £1m.”

Health and social care secretary, Matt Hancock, previously told MPs that refrigerated storage could cost “tens of millions”, but Hammond’s written answer clarified that this would include other types of storage too.

The Department of Health and Social Care (DHSC) previously told The Pharmaceutical Journal in December 2018 that drugs companies were being asked to maintain a rolling six-week stockpile for six months if the UK left the EU without a deal.

In his parliamentary answer, Hammond also admitted that that the DHSC would still have to pay for “some capital costs already incurred by the contractors in the event of a deal being approved by parliament”.

He said: “In that scenario, warehouse providers are required to decommission the additional capacity.

“The department has also put in place measures to minimise precommitted expenditure in the event of a deal being achieved.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206005

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.